ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma

SAN FRANCISCO and SUZHOU, China, Dec. 8, 2025 /PRNewswire/ — Innovent Biologics,…

Federation secures prestigious Victorian International Education Award wins

BALLARAT, Australia, Dec. 8, 2025 /PRNewswire/ — Federation University Australia is the type…

Daesang Group's "Vietnam Scholarship Quiz Show" Advances Youth Talent Development Through Respect

Record participation as over 100,000 students nationwide compete in Vietnam’s premier academic…

Dulwich College Ranjit Murugason Sustainability Fund Secures Renewed Support from LGT Bank Singapore to Advance Student-Led Initiatives

SINGAPORE, Dec. 8, 2025 /PRNewswire/ — The Dulwich College Ranjit Murugason Sustainability Fund is…

TenPay Global and Mastercard collaborate to enable fast and secure remittances to Weixin Pay

SINGAPORE, Dec. 8, 2025 /PRNewswire/ — TenPay Global, Tencent’s cross-border payment platform,…

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) delivers statistically significant and clinically meaningful improvement in overall survival benefit for Asian patients with EGFR-mutated non-small cell lung cancer in the Phase 3 MARIPOSA study

SINGAPORE, Dec. 8, 2025 First and only chemotherapy-free combination in the first-line…

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ — The Global Health Innovative Technology (GHIT) Fund announced…

Global Times: Mogao Caves' mural paintings meet modern technology

BEIJING, Dec. 8, 2025 /PRNewswire/ — The flying Apsaras dance across the…